Bioheart, Invitrx sign licensing agreement for adipose derived stem cells – Pharmaceutical Business Review
|
Bioheart, Invitrx sign licensing agreement for adipose derived stem cells
Pharmaceutical Business Review Invitrx Therapeutics specializes in the culture and engineering of adult stem cells, new products and therapies that are used in aesthetics, wound closure, and healing, as well as plastic and reconstructive surgery. Since 10 years, Invitrx team has … |
